C.M.R. Remédios

44 papers receiving 331 citations

Peers

C.M.R. Remédios
Comparison fields: 5 of 63
  • Materials Chemistry 178
  • Electronic, Optical and Magnetic Materials 133
  • Physical and Theoretical Chemistry 84
  • Electrical and Electronic Engineering 46
  • Inorganic Chemistry 35
Replace Charles J. McMonagle with:
Charles J. McMonagle France
R. Vasanthi India
Hongwei Zhou China
Łukasz Hetmańczyk Poland
Yu. A. Titov Ukraine
D. Schwarzenbach France
Н. М. Хамалетдинова Russia
Neelam Singh India
Yuan Su China
Paul Tissot Switzerland
C.M.R. Remédios relative to Charles J. McMonagle France Charles J. McMonagle's profile →
Citations per field
00.5×10×14×
Charles J. McMonagle · 1×
Citations per year

Countries citing papers authored by C.M.R. Remédios

Since Specialization
Citations

This map shows the geographic impact of C.M.R. Remédios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.M.R. Remédios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.M.R. Remédios more than expected).

Fields of papers citing papers by C.M.R. Remédios

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.M.R. Remédios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.M.R. Remédios. The network helps show where C.M.R. Remédios may publish in the future.

Co-authorship network of co-authors of C.M.R. Remédios

This figure shows the co-authorship network connecting the top 25 collaborators of C.M.R. Remédios. A scholar is included among the top collaborators of C.M.R. Remédios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.M.R. Remédios. C.M.R. Remédios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 1
4 6
5 2
6 1
7 6
8 2
9 2
10 0
11 2
12 15
13 6
14 3
15 1
16 4
17 6
18 2
19 1
20 18

About C.M.R. Remédios

C.M.R. Remédios is a scholar working on Physical and Theoretical Chemistry, Electronic, Optical and Magnetic Materials and Materials Chemistry, having authored 47 papers that have together received 338 indexed citations. Recurring topics across this work include Crystallography and molecular interactions (18 papers), Nonlinear Optical Materials Research (15 papers) and X-ray Diffraction in Crystallography (12 papers). The work is most often cited by research in Physical and Theoretical Chemistry (84 citations), Electronic, Optical and Magnetic Materials (133 citations) and Materials Chemistry (178 citations). C.M.R. Remédios has collaborated with scholars based in Brazil, Canada and United Kingdom. Frequent co-authors include Paulo Freire, F. E. A. Melo, J. M. Sasaki, Alan Silva de Menezes, M.A. Miranda, Sérgio L. Morelhão, Adenílson O. dos Santos, J. Mendes Fílho, Lisandro Pavie Cardoso and J.A. Lima. Their work appears in journals such as Physical Review B, Molecules and Journal of Applied Crystallography.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026